IL33 and neoplasm: Anti-fungal treatment significantly decreased intra-tumor fungi and pancreatic ductal adenocarcinoma tumor burden, increased survival via IL-33 secretion and suppressed recruitment of type 2 innate lymphoid cells (ILC2) and Th2 cells in the tumor microenvironment [66].